News related to Kristalose (Lactulose) and/or conditions it is approved for
Drug Relieves MS Constipation -- at a Price (CME/CE)
Source: MedPage Today Gastroenterology [2013.06.02]
ORLANDO (MedPage Today) -- Treatment of constipation in multiple sclerosis patients with lubiprostone (Amitiza) increased spontaneous bowel movements but also appeared to induce diarrhea, a small trial indicated.
Constipation And Other Bowel Problems Afflict 72 Percent Of Pregnant Women
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2013.05.22]
Nearly 3 out of 4 pregnant women experience constipation, diarrhea or other bowel disorders during their pregnancies, a Loyola University Medical Center study has found. But such bowel disorders only minimally affect a pregnant woman's quality of life, the study found...
Digestive Disorders Pictures Slideshow: Constipation Myths and Facts
Source: MedicineNet Constipation Specialty [2013.05.09]
Title: Digestive Disorders Pictures Slideshow: Constipation Myths and Facts
Category: Slideshows
Created: 5/9/2013 12:00:00 AM
Last Editorial Review: 5/9/2013 12:00:00 AM
Health Tip: Help Prevent Constipation
Source: MedicineNet Constipation Specialty [2013.02.22]
Title: Health Tip: Help Prevent Constipation
Category: Health News
Created: 2/22/2013 8:35:00 AM
Last Editorial Review: 2/22/2013 12:00:00 AM
Linzess (Linaclotide) For IBS With Constipation Or Chronic Idiopathic Constipation Now Available, USA
Source: Irritable-Bowel Syndrome News From Medical News Today [2012.12.27]
Linzess (linaclotide), a medication for irritable bowel syndrome (IBS) with constipation or chronic idiopathic constipation is now available in American pharmacies, Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc announced...
Linaclotide Given Positive CHMP Opinion For Irritable Bowel Syndrome With Constipation
Source: Irritable-Bowel Syndrome News From Medical News Today [2012.10.01]
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) have announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the marketing approval for Constella® (linaclotide 290 micrograms), for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation (IBS-C) in adults...
Constipation
Source: MedicineNet Amyotrophic Lateral Sclerosis Specialty [2012.09.19]
Title: Constipation
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/19/2012 12:00:00 AM
IBS-C And Chronic Idiopathic Constipation Treatment LINZESS (Linaclotide) Receives FDA Approval
Source: Irritable-Bowel Syndrome News From Medical News Today [2012.09.06]
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today that LINZESS™ (linaclotide) was approved by the U.S. Food and Drug Administration (FDA) as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC)...
Linzess (Linaclotide) Approved For IBS And Constipation, And Chronic Idiopathic Constipation
Source: Irritable-Bowel Syndrome News From Medical News Today [2012.08.31]
Linzess (linaclotide), for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation, has been approved by the Food and Drug Administration (FDA), USA. The approval is for adult patients only. "Idiopathic" means "of unknown cause". Chronic constipation affects approximately 63 million Americans, says the NIH (National Institutes of Health)...
Study: Constipation May Cause Bed-wetting
Source: MedicineNet Bedwetting Specialty [2012.01.31]
Title: Study: Constipation May Cause Bed-wetting
Category: Health News
Created: 1/31/2012 11:00:00 AM
Last Editorial Review: 1/31/2012 12:00:00 AM
Laxatives for Constipation
Source: MedicineNet Anal Fissure Specialty [2011.09.14]
Title: Laxatives for Constipation
Category: Diseases and Conditions
Created: 9/24/1999 7:06:00 AM
Last Editorial Review: 9/14/2011 12:00:00 AM
|
